Description

2-Fluoro-5-((8-Methoxy-4-Oxo-3,4-Dihydrophthalazin-1-Yl)Methyl)Benzoic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic benzoic acid structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents targeting specific biological pathways. It is primarily utilized by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in the production of active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, especially those containing phthalazinone and benzoic acid pharmacophores.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for developing new therapeutic molecules.
• API Development: Serves as a precursor in the multi-step synthesis of potential Active Pharmaceutical Ingredients (APIs) for various disease targets.
• Biochemical Tool Compound: May be employed in biochemical assays and as a probe to study enzyme inhibition or receptor binding activities.
• Custom Synthesis: Starting material for contract manufacturing and custom synthesis services for specialized client projects.
• Academic Research: Used in university and institutional labs for exploratory research in organic synthesis and drug discovery.

Basic Information

Product Name	2-Fluoro-5-((8-Methoxy-4-Oxo-3,4-Dihydrophthalazin-1-Yl)Methyl)Benzoic Acid
CAS No.	1174044-71-3
Molecular Formula	C₁₇H₁₃FN₂O₄
Molecular Weight	328.30 g/mol
Synonyms	1,4-Dihydro-8-methoxy-1-[[4-(carboxy)-2-fluorophenyl]methyl]-4-oxophthalazine; 2-Fluoro-5-[(8-methoxy-4-oxo-3,4-dihydro-1-phthalazinyl)methyl]benzoic acid; 2-Fluoro-5-((8-methoxy-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid; 1174044-71-3; Benzoic acid, 2-fluoro-5-[(8-methoxy-4-oxo-3,4-dihydro-1-phthalazinyl)methyl]-
EINECS	Contact for details

Quality Control

Our 2-Fluoro-5-((8-Methoxy-4-Oxo-3,4-Dihydrophthalazin-1-Yl)Methyl)Benzoic Acid is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high purity suitable for research and development applications. We provide comprehensive Certificates of Analysis (COA) with each batch, detailing purity, identity, and impurity profiles. Our quality systems are designed to meet the stringent requirements of pharmaceutical intermediate supply, supporting our clients' regulatory and compliance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.